ACPU
SYNH

Arrowgrass Capital Partners (US)’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-136,702
Closed -$8M – 629
2017
Q2 		$8M Sell
136,702
-312,024
-70% -$16.2M 0.06% 332
2017
Q1 		$20.6M Buy
+448,726
New +$22.3M 0.21% 135
2015
Q4 		– Sell
-85,220
Closed -$3.41M – 479
2015
Q3 		$3.41M Buy
+85,220
New +$3.72M 0.06% 196

Other funds holding SYNH

THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s SYNH Position: Q3 2017 in Review

Arrowgrass Capital Partners (US) sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2017, closing a stake of 136,702 shares — an estimated $8M sold.

Arrowgrass Capital Partners (US) first reported a position in SYNH in Q3 2015 and held it in 3 quarters. The position peaked at $20.6M in Q1 2017. 238 funds tracked by Wall St. Rank hold SYNH as of Q3 2017.

  • Arrowgrass Capital Partners (US) reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2017 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 136,702 Syneos Health, Inc. Class A Common Stock shares in Q3 2017, an estimated $8M.
  • Arrowgrass Capital Partners (US) first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 3 quarters.
  • Arrowgrass Capital Partners (US)'s Syneos Health, Inc. Class A Common Stock position peaked at $20.6M in Q1 2017.
  • 238 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2017.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2017, filed 14 Nov 2017.